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 NOTE 
Missouri Shows the True Meaning of the 
“Show-Me” State – Missouri’s Unfounded 
Hesitation to Enact a Prescription Drug 
Monitoring Program 
Emma Masse* 
I.  INTRODUCTION 
Drug overdoses in the United States have more than doubled over the last 
two decades, resulting in more deaths due to opioid overdoses than to vehicle 
accidents.1  In 2014, there were over 28,000 deaths due to opioid abuse.2  Out 
of the total number of drug overdoses in 2013, illicit drugs were not the primary 
culprits.3  Rather, over half of the deaths were associated with prescription 
drugs.4  Opioids contributed to 42,249 deaths in 2016 and were responsible for 
the vast majority of accidental overdoses, which more than quintupled since 
1999.5  As prescription drug deaths became an epidemic, forty-nine states as 
of early 2017 joined to combat this trend by enacting prescription drug moni-
toring programs.6  After New Hampshire became the forty-ninth link in the 
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 1. Maggie Fox, Drug Overdoses Spur Rise in Accidental Deaths, Says Report, 
NBC NEWS (June 17, 2015, 12:55 AM), http://www.nbcnews.com/health/health-
news/fifty-ways-die-report-finds-accidental-deaths-n377131. 
 2. Dan Margolies, Ag Secretary Vilsack Says Long Past Time for Missouri to 
Adopt Drug Monitoring Program, KCUR 89.3 (June 13, 2016), http://kcur.org/post/ag-
secretary-vilsack-says-long-past-time-missouri-adopt-drug-monitoring-pro-
gram#stream/0. 
 3. Jacob O’Brien, Note, A Review and Evaluation of Indiana’s INSPECT System 
and Governing Legislation: Maximizing Potential Impact on Public Health, 10 IND. 
HEALTH L. REV. 701, 702 (2013). 
 4. Fox, supra note 1. 
 5. Opioid Overdose: Drug Overdose Death Data, CTRS. FOR DISEASE CONTROL 
& PREVENTION, https://www.cdc.gov/drugoverdose/data/statedeaths.html (last updated 
Dec. 19, 2017) [hereinafter Opioid Overdose]. 
 6. Jason Hancock & Andy Marso, Gov. Eric Greitens Orders Prescription Drug 
Monitoring Program for Missouri, KAN. CITY STAR (July 17, 2017, 12:33 PM), 
1
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chain in June of 2012,7 the “Show-Me” state stood alone from 2012 to 2017 in 
the battle against prescription drug abuse.8 
All fifty states have now enacted a prescription drug monitoring program 
(“PDMP”).9  A PDMP is a statewide database that monitors the prescriptions 
distributed within a given state.10  PDMPs have been shown to act as useful 
tools in a variety of ways.  For example, they aid in decreasing prescription 
drug abuse through intervention, and they are powerful mechanisms to help 
physicians realize if they are unknowingly treating addicts searching for un-
necessary painkillers11 (this is known as “doctor shopping”).12  Because pre-
scription drug abuse is one of the most pressing drug-related problems in the 
United States,13 PDMPs have the ability to save lives.  Between the years of 
1999 and 2014, drug overdose fatalities increased by 386%,14 and out of the 
28,000 opioid abuse-inflicted deaths alluded to above, over 1000 of the lives 
claimed belonged to Missourians.15  This is no surprise considering Missouri’s 
controlled substance death rate is far higher than the national average.16 
This Note examines the reasons why Missouri took so long to enact any 
form of PDMP legislation.  Part II of this Note introduces the background of 
PDMPs as they emerged across the country.  Part III highlights the hurdles that 
states encountered in passing PDMP legislation and how they overcame them.  
Part III also discusses some of the recent developments in Missouri’s own ef-
forts to pass PDMP legislation.  Part IV of this Note examines the benefits of 




 7. Memorandum from NH Prescription Drug Monitoring Program to Licensed 
NH Prescribers & Pharmacists (Oct. 29, 2014), http://www.nhmgma.com/as-
sets/pdmp%20memo%20lttrhead%20102914%20final.pdf. 
 8. See Alan Schwarz, Missouri Alone in Resisting Prescription Drug Database, 
N.Y. TIMES (July 20, 2014), https://www.nytimes.com/2014/07/21/us/missouri-alone-
in-resisting-prescription-drug-database.html. 
 9. Prescription Drug Monitoring Frequently Asked Questions (FAQ), 
PRESCRIPTION DRUG MONITORING PROGRAM TRAINING & TECH. ASSISTANCE CTR., 
http://www.pdmpassist.org/content/prescription-drug-monitoring-frequently-asked-
questions-faq (last visited Apr. 2, 2018). 
 10. Id. 
 11. Id. 
 12. Doctor Shopping Law and Legal Definition, USLEGAL, https://defini-
tions.uslegal.com/d/doctor-shopping/ (last visited Apr. 2, 2018) (for brief background 
on doctor shopping). 
 13. See Prescription Drug Monitoring Frequently Asked Questions (FAQ), supra 
note 9. 
 14. Prescription Drug Monitoring Programs Save Lives.  Missouri Needs One 
Now., SHATTER PROOF, https://www.shatterproof.org/prescription-drug-monitoring-
programs-save-lives-missouri-needs-one-now (last visited Apr. 2, 2018). 
 15. Margolies, supra note 2. 
 16. Id. 
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well as aiding prescribers in knowing exactly what their patients have previ-
ously been prescribed.  Part IV then discusses the criticisms PDMP legislation 
has received across the nation, specifically in Missouri.  Finally, this Note con-
cludes with a brief comment on the outlook of drug abuse in Missouri now that 
Missouri has joined the war against prescription drug abuse. 
II.  LEGAL BACKGROUND 
This Part traces the history of PDMPs in the United States and discusses 
how PDMPs have evolved to become law across the country.  Though PDMPs 
are not mandated in every state, the federal government provides financial aid 
to states that want to construct and implement statewide PDMPs as part of a 
combative fight against drug abuse.17  As of 2012, all states had implemented 
operational PDMPs or had enacted PDMP legislation, except for Missouri.18  
In 1918, New York became the first state to enact a PDMP.19  California and 
Hawaii followed suit in the early 1940s, chased by many others during the 
1970s to 1990s, including Washington, Texas, Illinois, Michigan, Rhode Is-
land, and Indiana.20  In 1991, Oklahoma became the first state to enact an elec-
tronic PDMP.21 
A. What Do PDMPs Monitor? 
Though each state’s PDMP differs, the basic information collected and 
utilized through the programs remains consistent.  Dispensers22 are asked to 
submit data that includes patient identification (name, address, birth date, gen-
der), prescriber information, dispenser information, drug information, quantity 
dispensed, and date dispensed.23  Specifically, PDMPs are formulated to oper-
ate by monitoring the collected information for possible abuse or diversion 
(such as funneling opioids into illegal uses, etc.) and can prove to be life-saving 
 
 17. Neha Casturi, Comment, A Modern Day Apocalypse: The Pill Mill Epidemic, 
How It Took Texas by Storm, and How Texas Is Fighting Back, 14 TEX. TECH. ADMIN. 
L.J. 445, 459–60 (2013). 
 18. See Prescription Drug Monitoring Program, OFF. PROF. LICENSURE & 
CERTIFICATION, https://www.oplc.nh.gov/pharmacy/drug-monitoring.htm (last visited 
Apr. 2, 2018). 
 19. ALL. OF STATES WITH PRESCRIPTION MONITORING PROGRAMS, PRESCRIPTION 
MONITORING PROGRAMS 5 (Oct. 18, 2010), 
http://www.pdmpassist.org/pdf/PPTs/LI2010/1-PMP-Overview-History.pdf. 
 20. Id. 
 21. Id. 
 22. Id. at 13 (Dispensers include pharmacies in the state, out of state pharmacies 
licensed to dispense into the state, hospitals, and practitioners dispensing out of their 
office.). 
 23. Id. at 12. 
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devices.24  For example, consider a situation in which a patient visits a physi-
cian in hopes of obtaining opioids in addition to the prescription medications 
he has already been prescribed by his treating physician.  Had he tried to obtain 
unnecessary opioids in Missouri prior to July of 2017, he would have likely 
succeeded with no monitoring program in place for a prescriber to reference to 
see if the patient had already been prescribed the medication.  However, if the 
patient attempts the same goal in Missouri today, the likelihood of the patient 
receiving a prescription for unnecessary opioids drops significantly if his pre-
scriber is able to verify through a statewide database whether another physician 
has already prescribed the patient these medications.  This is, at its most basic 
level, how PDMPs help to save lives across the nation. 
With respect to the prescription medications monitored by PDMPs, the 
Controlled Substances Act25 is the federal drug policy through which the 
United States classifies and categorizes prescription medications into five sep-
arate classes (referred to as “Schedules”) based upon the federal government’s 
viewpoint of each drug’s potential abuse, dependency, and addiction level.26  
Roughly sixty percent of state PDMPs collect information on Schedules II 
through V drugs, with the rest primarily collecting Schedules II through IV 
only.27 
Schedule I drugs (the most restricted schedule) include non-prescription, 
illegal drugs, such as heroin, LSD, and cocaine, and are not monitored by many 
PDMPs because they have no accepted medical use and therefore are not the 
type of drugs PDMPs first and foremost seek to monitor.28  Schedules II, III, 
and IV drugs contain approved prescription medications that have varying de-
grees of potential for abuse, dependence, and addiction.29  For example, Sched-
ule II drugs include drugs that have the highest severity of addictive potential, 
such as codeine, fentanyl (50 to 100 times more powerful than morphine),30 
oxycodone, morphine, and the barbiturates.31  Opioids also fall under Schedule 
II drugs.32  Schedule III drugs have a lower potential for dependence and abuse 
than Schedule II drugs and include steroids and low-dose codeine.33  With an 
even lesser anticipation of addictive outcomes, Schedule IV drugs include the 
majority of anti-anxiety medications, sedatives, and sleep aids.34  Finally, 
Schedule V drugs, which go un-monitored by some PDMPs, have a lower po-
 
 24. See Opioid Overdose, supra note 5. 
 25. 21 U.S.C. §§ 801–904 (2012). 
 26. 21 U.S.C. § 812 (2012). 
 27. ALL. OF STATES WITH PRESCRIPTION MONITORING PROGRAMS, supra note 19, 
at 10. 
 28. See § 812. 
 29. Id. 
 30. Margolies, supra note 2. 
 31. § 812. 
 32. Id. 
 33. Id. 
 34. See id. 
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tential for abuse and addiction and include prescribed drugs for common ail-
ments, such as coughing or diarrhea.35  Schedule I and Schedule V drugs appear 
at opposite ends of the spectrum but go unmonitored for different reasons.  Be-
cause Schedule I drugs are inherently illegal in nature, they are not the “pre-
scribed” drugs that PDMPs seek to monitor, whereas Schedule V drugs’ abuse 
potential is so low that many states choose to focus their efforts on monitoring 
the more addictive Schedules II through IV drugs. 
B. Funding of PDMPs 
Relative to most states’ total budgets, PDMPs do not require a large sum 
of money to begin operating effectively.  An average PDMP’s startup cost 
ranges between $450,000 to $1,500,000.36  Some of the program costs may 
include sources of hardware (servers), the actual software to operate the data-
base, information security mechanisms, connectivity between pharmacies and 
prescribing physicians, staff, and overhead expenses.37  States finance their 
PDMPs through state funds, licensing fees, registration fees, and direct-support 
organizations.38  But often even a combination of these efforts still leaves states 
without all of the funding they need.  In an effort to curb prescription drug 
abuse and provide an incentive to states committed to developing a PDMP, the 
federal government created two grant programs that support PDMPs – the Har-
old Rogers PDMP grant and the National All Schedules Prescription Electronic 
Reporting Act (“NASPER”).39 
Enacted in 2002, the main goal of the Harold Rogers grant is “to enhance 
the capacity of regulatory and law enforcement agencies and public health of-
ficials to collect and analyze controlled substance prescription data . . . through 
a centralized database administered by an authorized state agency.”40  It is a 
competitive grant and is dispersed by the Department of Justice, the Office of 
Justice Programs, and the Bureau of Justice Assistance.41  The grant aids states 
in the “planning, implementation, and enhancement of their PDMPs,” and 
states may apply for the Harold Rogers grant for any of these three purposes.42  
States lacking operational PDMPs typically apply for planning grants (of up to 
$50,000), states with regulations requiring the implementation of a program 
like a PDMP may apply for implementation grants (of up to $400,000), and 
 
 35. See id. 
 36. KRISTIN FINKLEA ET AL., PRESCRIPTION DRUG MONITORING PROGRAMS 8 
(Mar. 24, 2014), https://fas.org/sgp/crs/misc/R42593.pdf. 
 37. See Harold Rogers Prescription Drug Monitoring Program (PDMP), GRANTS 
OFF., http://grantsoffice.com/GrantDetails.aspx?gid=23731 (last visited Apr. 2, 2018). 
 38. FINKLEA ET AL., supra note 36, at 9. 
 39. Id. at 14, 16. 
 40. Harold Rogers Prescription Drug Monitoring Program (PDMP), supra note 
37. 
 41. Id. 
 42. FINKLEA ET AL., supra note 36, at 14. 
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states that currently have operational PDMPs but wish to enhance them may 
apply for enhancement grants (of up to $400,000).43 
Three years after the creation of the Harold Rogers grant, the NASPER 
grant emerged and is currently dispersed by the Department of Health and Hu-
man Services, the Substance Abuse and Mental Health Services Administra-
tion, and the Center for Substance Abuse Treatment.44  The program was orig-
inally an amendment to the Public Health Service Act and now provides fund-
ing for states to either establish a PDMP or to improve their existing PDMPs.45  
NASPER has two primary goals: “(1) [to] foster the establishment of state-
administered PDMPs that providers can access for the early identification of 
patients at risk for addiction in order to initiate appropriate interventions, and 
(2) [to] establish a set of best practices for new PDMPs and improvement of 
existing PDMPs.”46  The NASPER grant amount is determined by a formula 
that provides a base of one percent of the total funding to each state.47   The 
rest is distributed based on the number of pharmacies in the state compared to 
the number of pharmacies in states with approved NASPER applications.48 
The agencies that administer the funds and the way the funds are dis-
persed differ between the Harold Rogers grant and the NASPER grant, but the 
end goal of both programs remains the same – to help support state PDMPs in 
the fight against prescription drug abuse and addiction.  With the average 
PDMP startup cost ranging from $450,000 to just over $1.5 million,49 states 
across the country have benefited from grants such as these.  Even with PDMP 
expenses being relatively inconsequential, states may have the opportunity to 
receive federal financial support when needed. 
C. Prescription Drug Abuse and the Criminal Justice System 
Over the last few decades, the number of individuals either incarcerated 
for prescription drug abuse or subjected to another form of criminal justice su-
pervision in the United States has increased to approximately 7.1 million.50  
Roughly half of these individuals qualify for a diagnosis of “drug abuse or de-
pendence.”51  Most individuals in prison for drug offenses do not receive the 
help they need, and incarceration as a means of addressing drug abuse has 
proven to be inadequate when reviewing recidivism rates.52  Additionally, from 
 
 43. Id. at 15. 
 44. Id. at 16. 
 45. Id. 
 46. Id. 
 47. Id. at 17. 
 48. See Harold Rogers Prescription Drug Monitoring Program (PDMP), supra 
note 37. 
 49. FINKLEA ET AL., supra note 36, at 8. 
 50. Redonna K. Chandler et al., Treating Drug Abuse and Addiction in the Crim-
inal Justice System, 301 JAMA 183, 183 (2009). 
 51. Id. 
 52. Id. 
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an economic standpoint, the costs associated with promoting a PDMP are neg-
ligible when compared to the average costs of incarceration ($31,307 for one 
year).53 
Through monitoring and supervision, a PDMP can provide a way for phy-
sicians and prescribers to realize when drug abuse occurs and provide an op-
portunity to encourage abusers to begin life-saving treatment.  The implemen-
tation of a statewide PDMP has the unique opportunity to help decrease pre-
scription drug abuse and unclutter the criminal justice system while simultane-
ously alerting those in a position of power to provide the necessary help some-
one desperately needs. 
D. Liberals, Conservatives, Independents . . . Everyone Is on Board 
Though the federal government is supportive in its efforts to financially 
aid state PDMPs, involvement at the state level is lacking.  When contrasted 
with the federal government, the states are far better equipped to handle the 
issues that PDMPs aim to eliminate.54  For example, states are in closer prox-
imity and can more efficiently address specific issues in their jurisdictions.55  
Additionally, states generally take control over medical and health-related 
fields when it comes to policymaking, and the prescribing and dispensing of 
prescription drugs are no exception.56  Articulated in Jacobson v. Massachu-
setts, the nation’s leading health law case decided in the early 1900s, Justice 
Harlan, writing for the United States Supreme Court, decided that the police 
powers of the state include the power to implement regulations when public 
health, safety, and welfare are at risk.57 
From 2012 to 2017, Missouri stood alone in its resistance to fight pre-
scription drug abuse.  The forty-nine other states – liberal, conservative, and 
moderate – had managed to overcome the ethical, legal, and privacy concerns 
that Republican Missouri State Senator Rob Schaaf and other critics continued 
to oppose.58  Kentucky and Tennessee, both historically conservative states, 
were not only early adopters of state PDMPs but proponents of use mandates, 
 
 53. CBS News, The Cost of a Nation of Incarceration, SUNDAY MORNING (Apr. 
23, 2012, 5:15 PM), https://www.cbsnews.com/news/the-cost-of-a-nation-of-incarcer-
ation/. 
 54. Rebecca L. Haffajee, Preventing Opioid Misuse with Prescription Drug Mon-
itoring Programs: A Framework for Evaluating the Success of State Public Health 
Laws, 67 HASTINGS L.J. 1621, 1638 (2016). 
 55. Id. 
 56. Id. at 1638–39. 
 57. Jacobson v. Massachusetts, 197 U.S. 11, 24–25 (1905). 
 58. Megan Thielking, Missouri Is the Only State Not Monitoring Prescription 
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thus requiring prescribers to utilize the database prior to prescribing a con-
trolled substance that harbors potentially addictive or abusive characteristics.59  
Use mandates require that prescribers follow and adhere to their state PDMPs 
as opposed to merely consult them – not all states mandate the use of PDMPs.60  
Close to half of state PDMPs legally mandate prescriber use of the systems.61  
These mandates did not come without opposition from physicians who thought 
the query prior to prescribing was burdensome, but twenty-two states so far 
have overcome this hurdle.62 
Granted, many state PDMPs could be revamped and enhanced, perhaps 
by increasing the number of states that mandate prescriber query of the data-
bases before writing a prescription.  It is uplifting that as of early 2018, all fifty 
states at least have in effect a program with the end goal of reducing prescrip-
tion drug and opioid abuse and misuse in the United States. 
III.  RECENT DEVELOPMENTS 
Bob Twillman,63 the Executive Director of the Academy of Integrative 
Pain Management in Kansas City, Missouri, noted in an interview that there 
are serious prescription drug problems in the St. Louis area.64  Dr. Twillman 
stated that these problems are historically due in part to Illinois patients’ easy 
access across the state line because it is difficult to catch someone to build a 
case if there exists no method by which to effectively catch them.65  Abuse 
evidence in Missouri is anecdotal at best – with no way to track abusers, there 
is no way to catch them.  This Part traces the recent developments regarding 
PDMP legislation in Missouri, the arguments in favor of the legislation, as well 
as how Missouri positively distinguishes itself regarding privacy concerns with 
the program. 
A.  Recent Efficacy of PDMPs 
In 2006, the Bureau of Justice Assistance reported that when compared to 
states that do not have operational PDMPs, the states with PDMPs decreased 
 
 59. Rebecca L. Haffajee et al., Opinion, Mandatory Use of Prescription Drug 
Monitoring Programs, 313 JAMA 891, 891 (2015). 
 60. Id. 
 61. Id. 
 62. Id.  (There exists “early evidence from states that have deployed mandates to 
demonstrate their potential to reduce opioid abuse.”) 
 63. For more information about Dr. Bob Twillman, see AIPM Team, ACAD. 
INTEGRATIVE PAIN MGMT., http://www.integrativepainmanagement.org/page/team2 
(last visited Apr. 2, 2018). 
 64. Telephone Interview with Bob Twillman, Executive Director, Academy of In-
tegrative Pain Management (Feb. 2, 2017). 
 65. Id. 
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the number of prescription drugs readily available to the public.66  The Bureau 
of Justice Assistance report concluded that as a result, PDMPs effectively re-
duced the odds of prescription drug abuse.67  For example, it is reported that 
doctor shopping decreased by seventy-five percent just one year after New 
York started mandating that prescribers consult New York’s PDMP database 
prior to dispensing prescription medications.68  Additionally, surveys taken by 
prescribers across the country have reported that PDMPs have been an instru-
mental tool in identifying and reducing opioid abuse,69 which is an integral 
reason why PDMPs are encouraged by the federal government.70  According 
to the Centers for Disease Control and Prevention (“CDC”), “[PDMPs] con-
tinue to be among the most promising state-level interventions to improve opi-
oid prescribing, inform clinical practice, and protect patients at risk.”71 
Eighty-six percent of opioid prescriptions are written without checking a 
patient’s prescription medication history.72  As mentioned above,73 PDMPs are 
not mandated in all states, releasing prescribers from the obligation to follow 
them, but there has been evidence of decreased opioid dispensing in states that 
do mandate the programs.74  The reality is that many of the prevalent experi-
ences with prescription drug abuse begins – and grows – due to the opioids 
legally prescribed by patients’ treating physicians.75  But saving lives does not 
have to be – and should not be – controversial.76 
 
 66. Casturi, supra note 17, at 460–61 (citing RONALD SIMEONE & LYNN HOLLAND, 
EXECUTIVE SUMMARY: AN EVALUATION OF PRESCRIPTION DRUG MONITORING 
PROGRAMS, https://www.bja.gov/Publications/PDMPExecSumm.pdf (last visited Apr. 
2, 2018)).  However, it is important to remember that we do want prescription drugs to 
remain available to the public for all the good that they can do.  There is a reason they 
are FDA approved.  What PDMPs do is simply alert those equipped to hinder potential 
prescription drug abuse while ideally reducing the flow of prescription drugs to those 
populations. 
 67. Id. 
 68. Bram Sable-Smith, Political Gridlock Blocks Missouri Database for Fighting 
Drug Abuse, NPR (Apr. 12, 2016, 3:02 PM), https://www.npr.org/sections/health-
shots/2016/04/12/473870528/political-gridlock-blocks-missouri-database-for-
fighting-drug-abuse. 
 69. Id. 
 70. Id. 
 71. Opioid Overdose: What States Need to Know About PDMPs, CTRS. FOR 
DISEASE CONTROL & PREVENTION, https://www.cdc.gov/drugover-
dose/pdmp/states.html (last updated Oct. 3, 2017). 
 72. Prescription Drug Monitoring Programs Save Lives.  Missouri Needs One 
Now., supra note 14. 
 73. See Haffajee et al., supra note 59, at 891. 
 74. Prescription Drug Monitoring Programs Save Lives.  Missouri Needs One 
Now., supra note 14. 
 75. See Jennifer Cartright, Saving Lives Shouldn’t Be Controversial, SPRINGFIELD 
NEWS-LEADER (Feb. 15, 2017, 8:46 PM), http://www.news-leader.com/story/opin-
ion/readers/2017/02/15/saving-lives-controversial/97976574/. 
 76. Id. 
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B.  Early Opposition to PDMPs in Missouri 
Dr. Twillman noted that he has no doubt that Missouri would have en-
acted a PDMP before 2017 if it were not for the filibustering effects of Senator 
Schaaf.77  Dr. Twillman supports PDMP bills across the country and has testi-
fied in New Hampshire and Nebraska and even wrote the majority of the bill 
for Kansas.78  In addition to his Executive Director duties, Dr. Twillman cur-
rently serves as Chair of the PDMP Advisory Committee for the Kansas Board 
of Pharmacy.79 
Dr. Twillman stressed that privacy concerns were the root of why this bill 
took so long to pass the Missouri Senate.80  Republican State Representative 
Holly Rehder,81 creator of the House legislation, relentlessly urged that Mis-
souri needed this bill to pass sooner rather than later.82  Representative Rehder 
stated that Missouri experienced more overdoses, more addictions, and more 
deaths every week that passed by without a program in place.83  Alternatively, 
Senator Schaaf stated that Missouri was in no need of such a program and that 
PDMPs are unsuccessful altogether.84  Senator Schaaf has been quoted saying 
that “more people die of alcohol abuse and the effects of smoking of cigarettes 
than will ever die of opioid overdose.”85  When Senator Dave Schatz, carrier 
of the Missouri Senate version of the House bill, asked Senator Schaaf whether 
he would ever come around, Schaaf said that he would be willing to support 
the bill so long as it were in a way “that will protect our liberty.”86 
The risk of the encroachment on Missouri citizens’ personal liberties is 
outweighed by the public health benefit achieved by implementing a PDMP.  
Senator Schaaf described the effects of these lifesaving databases as “the heavy 
hand of government taking away your liberty.”87  However, the instances on 
record of PDMPs threatening the personal liberties of citizens are few and far 
between, with law enforcement officials, not the “30,000 people with 
usernames and passwords” (physicians), being the primary culprits. 88 
 
 77. Telephone Interview with Bob Twillman, supra note 64. 
 78. Id. 
 79. AIPM Team, supra note 63. 
 80. Telephone Interview with Bob Twillman, supra note 64. 
 81. For more information about Holly Rehder see Representative Holly Rehder, 
MO. HOUSE REPRESENTATIVES, http://www.house.mo.gov/MemberDe-
tails.aspx?year=2018&code=R&district=148 (last visited Apr. 2, 2018). 
 82. Alisa Nelson, Missouri Senator Threatens Filibuster on Proposed Drug Mon-
itoring Program, MISSOURINET (Apr. 20, 2016), http://www.mis-
sourinet.com/2016/04/20/missouri-senator-threatens-filibuster-on-proposed-drug-
monitoring-program/. 
 83. Id. 
 84. Id. 
 85. Id. 
 86. Id. 
 87. Sable-Smith, supra note 68. 
 88. Id. 
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1.  Florida Drug Enforcement Administration Breach 
As written, Missouri’s forthcoming statewide PDMP cannot lead to the 
breaches of privacy that have occurred in other states because Missouri’s law 
will include provisions that protect against such breaches.89  Though not com-
pletely unfounded, Senator Schaaf’s concerns about PDMPs encroaching on 
citizens’ liberties are lacking in support.  In 2013, over 3000 Florida residents’ 
personal information, including a list of prescription medications dispensed, 
was revealed to the public during a criminal investigation.90  At the time, Flor-
ida’s PDMP allowed full and free access to its database by law enforcement 
officials, and the Drug Enforcement Administration (“DEA”) filtered through 
Florida’s prescription drug database in search of a select few doctors and phar-
macies accused of forging prescriptions for painkillers.91  Numerous drug his-
tories were uncovered as part of the investigation and were subsequently re-
leased by the state for investigation.92  Once the list had circulated, a Daytona 
Beach attorney realized that his records were included and subsequently filed 
a lawsuit.93  Ultimately, the judge dismissed the case due to the absence of an 
unconstitutional search or seizure and further stated that the patients had a re-
duced expectation of privacy as the law mandates maintaining patient rec-
ords.94  Though ultimately not illegal in nature, it is understandable why the 
patients were alarmed in response to the breach. 
2.  Utah Privacy Breaches 
Like the case in Florida, law enforcement officials in Utah alarmed citi-
zens nationwide when they tapped into the records of almost 500 fire depart-
ment employees.95  DEA officials were alerted to the fact that local ambulances 
were coming up short on opioids.96  Without a warrant, an official accessed the 
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 90. George F. Indest, III, Florida Judge Rules Government Can Search Prescrip-
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state’s database and scanned the records on file for all employees of the fire 
department.97  No arrests were made, but two firefighters were charged with 
“acquiring controlled substances under false pretenses.”98  The officers respon-
sible for the intrusion of privacy stated that “[they] would not do anything that 
would go beyond the bounds of what the law allows . . . [and] were acting 
purely according to the way the state law permitted.”99  As a result of the Utah 
fire department breach, the state enacted a new law in 2015 that required a 
search warrant before law enforcement officials could root through the state 
PDMP’s database.100 
3.  Missouri Is Different 
Utah citizens’ concerns about the controversial privacy breach were ech-
oed by Scott Michelman, a Washington, D.C., attorney for Public Citizen, 
when he stated that “[p]ermitting law enforcement officers to go on fishing 
expeditions in people’s personal information, then mak[ing] their own un-
trained medical judgments and prosecut[ing] people as a result, has the power 
to destroy lives.”101  Michelman urged that these types of warrantless searches 
violate the unreasonable searches or seizures clause of the Fourth Amendment 
of the United States Constitution.102 
As written, Missouri’s bill is different.  Senator Schaaf has stated that 
“[PDMPs are] an infringement upon people’s privacy . . . . Most people don’t 
want the government to have that information and have it on a database in 
which many people can get it.”103  Contrary to Senator Schaaf’s concerns, the 
PDMP legislation for Missouri includes provisions that require law enforce-
ment officials to obtain a court-issued subpoena or a search warrant to even 
begin to have access to the substance database.104  Thus, probable cause is re-
quired to gain access to the records (something Utah’s statutes did not require). 
Representative Rehder argued that because the PDMP is an electronic da-
tabase of medical information, the same privacy laws govern this medical in-
formation.105  Also, Representative Rehder noted that Missouri is not the first 
state to encounter these concerns – all forty-nine other states have previously 
dealt with and overcome the exact privacy issues that Senator Schaaf worries 
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 100. Id. 
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 103. Josh Helmuth, Why Is Missouri the Only State Without Prescription Drug 
Monitoring?, KSHB KAN. CITY 2 (Oct. 18, 2016, 5:48 PM), 
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about.106  Therefore, Missouri had forty-nine examples from which to extract 
the very best policies that have been developed over the years.107  Before Gov-
ernor Eric Greitens signed the bill into effect, Representative Rehder repeat-
edly proffered that “Missouri is the only state that doesn’t have this. It’s very 
shameful . . . . It’s hurting our population so much.”108 
Though she was at the forefront of the argument, Representative Rehder 
was not the only Missouri politician trying to pass PDMP legislation.  On Feb-
ruary 15, 2017, Governor Greitens held a live chat where he publicly addressed 
his and the state’s concerns regarding the lack of a statewide PDMP.109  During 
his live chat, Governor Greitens committed to join the rest of the nation by 
beginning to create a PDMP database for Missouri.110  The fact that Missouri’s 
new governor made PDMP legislation a priority speaks volumes to the neces-
sity of the program and the support behind it. 
C. Senator Schaaf’s PDMP Bill Passes the Senate 
In opposition to Representative Rehder’s House bill, Senator Schaaf in-
troduced an alternative, which differed fundamentally from other PDMPs in 
the United States111 and has been characterized as a “sham” by its critics.112  In 
late February of 2017, Senator Schaaf’s bill passed the Senate and made its 
way to the House.113  The House considered both Senator Schaaf’s newly pro-
posed bill as well as Representative Rehder and Senator Schatz’s bill – the bill 
that was continuously filibustered by Senator Schaaf.114 
Senator Schaaf’s version of the bill would have forced physicians to sub-
mit to the Missouri State Health Department the names of every patient to 
whom they are considering prescribing painkillers.115  This is different from 
other states’ bills, which grant direct access to a patient’s controlled substance 
prescription history to registered medical professionals.116  In Senator Schaaf’s 
version, the state would alert the prescriber about any red flags that may appear 
in the patient’s medical history, and the prescriber would then decide whether 
to prescribe the medications or not.117  Opponents argued that the bill takes the 
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otherwise solely medical decision of whether a patient may be at risk for sub-
stance abuse out of the hands of those best equipped to handle them – physi-
cians.118   Representative Rehder stated that to her, “the most important part of 
a PDMP is doctors having that access to see what their patients are on so they 
can make those medical decisions based on accurate information” and that 
“[u]ntil we give our physicians the tools that they need to make the right deci-
sions . . . we’re not going to touch this problem.”119 
Jeff Howell of the Missouri State Medical Association stated that Senator 
Schaaf’s bill “[is] unlike anything any other state has done,” and that “[i]n other 
states, a physician or prescriber can just get on and see what the prescribing 
history has been.”120  With Kansas City and St. Louis bordering multiple states, 
Jeff Howell expressed how important it was for Missouri to follow suit and 
create a database that conforms to the same guidelines as the rest of the country 
for the sake of uniformity.121  Not surprisingly, the Missouri State Medical As-
sociation criticized Senator Schaaf’s bill, going so far as to call it a “fake 
[PDMP] bill,” while fully supporting Representative Rehder and Senator 
Schatz’s legislation.122  Senator Schaaf seemed unwilling to compromise, as he 
notified the St. Louis Post Dispatch of his intentions to further filibuster Rep-
resentative Rehder and Senator Schatz’s bill, stating that “[he would] just as 
soon not have a PDMP.”123 
D.  Support on All Fronts 
It is remarkable that the senators and representatives who were in favor 
of passing PDMP legislation are politicians who control majorities in both 
chambers and, most recently, the governorship.  Further, the politicians at the 
forefront of attempts to pass the legislation included conservative Republicans 
like Representative Rehder and Governor Greitens, who arguably are even 
more concerned with privacy issues than politicians on the left.124  The majority 
in Missouri cleared the first hurdle of gaining bipartisan support, and when 
asked why Missouri was the only state that had not enacted a PDMP, officials 
 
 118. Id.  Larry Pinson, who serves on the board of the National Association of State 
Controlled Substances Authorities, proclaimed his dissatisfaction by arguing that by 
enacting Senator Schaaf’s legislation, “You are charging [the bureau] with making a 
medical decision and that doesn’t make any sense to me . . . . How are they going to 
know if there is a true medical reason for that patient to need a narcotic?”  Id. (alteration 
in original). 
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 120. Thielking, supra note 58. 
 121. Id. 
 122. Id.; MO Medical Assn (@MOMedicalAssn), TWITTER (Feb. 22, 2017, 7:36 
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continued to point to Senator Schaaf’s filibustering attempts.125  Senator Schaaf 
had combatted bipartisan proponents including former Missouri Attorney Gen-
eral Chris Koster, U.S. Agriculture Secretary and former governor of Iowa 
Tom Vilsack, and Missouri Senator Claire McCaskill.126 
In 2016, President Barack Obama asked Secretary Vilsack to lead a task-
force in charge of combatting the prescription drug abuse epidemic sweeping 
the nation, with particular attention to the abuse in rural communities.127  When 
questioned about the severity of the problem, Secretary Vilsack stated in a 
news report that “in a state like Missouri, it definitely is an issue.  With a death 
rate . . . much higher than the national average, it’s a serious problem in rural 
areas.”128  Secretary Vilsack proceeded to note that the President himself real-
ized the necessity for “aggressive effort” to “expand prevention opportuni-
ties.”129  When asked why the administration waited so long to combat the pre-
scription drug abuse epidemic, Secretary Vilsack stated that “[t]he only state, 
unfortunately, in the union that does not have a monitoring program is the state 
of Missouri.  [Missouri] really does need to rectify that, because there’s too 
much opportunity for doctor shopping if you don’t have a monitoring sys-
tem.”130  Secretary Vilsack concluded his interview with this proclamation: 
If you don’t have a monitoring system, then essentially you are encour-
aging people to continue to go to multiple prescribers and get multiple 
prescriptions.  You’re encouraging and making it harder for states that 
do have monitoring programs to avoid people crossing over state lines 
to get access to additional medications.  There are ways to deal with 
whatever privacy concerns folks have in the state legislature about this, 
but at the end of the day it’s a sad statement, I think . . . that [Missouri 
is] the only state in the country that doesn’t have a monitoring program 
. . . . St. Louis County and St. Louis City have adopted their own ordi-
nances, and the reality is, the time is long past for Missouri to add itself 
to the other states that do have monitoring programs.131 
By leaving a hole in the national and intricately created PDMP network, 
the efforts to fight prescription drug abuse nationwide were undeniably hin-
dered for years by Missouri’s reluctance to cooperate.  Even a pharmaceutical 
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company in St. Louis that manufactures opioids, Mallinckrodt Pharmaceuti-
cals, stated that it supported Representative Rehder and Senator Schatz’s bill 
to end the opioid epidemic.132 
Governor Greitens, Representative Rehder, Secretary Vilsack, and count-
less other politicians from both political parties realized that the time had come 
to put an end to the unjustified opposition to a PDMP in Missouri.  During his 
live chat on February 15, Governor Greitens lamented that he knew creating 
this life-saving database was “an incredibly important issue . . . . We can get 
this done.  I know we can get this done.”133  It is significant that the moderate, 
liberal, and conservative views all point to the same endgame – to curb pre-
scription drug abuse. 
Ultimately, on July 17, 2017, Governor Greitens signed an executive or-
der requiring the Missouri Department of Health and Senior Services to begin 
creating a statewide PDMP.134  Secretary Tom Price of the United States De-
partment of Health and Human Services stated that he “commend[ed] Missouri 
Governor Eric Greitens for taking a strong step in fighting the opioid epidemic 
by joining other states in establishing a [PDMP]” and that he “commend[ed] 
Governor Greitens for his leadership in Missouri as we all work to detect and 
deter the abuse of prescription drugs.”135  The new statewide PDMP is antici-
pated to compliment the currently existing St. Louis County PDMP, as the 
statewide PDMP will monitor prescribers and dispensers of Schedule II to 
Schedule IV controlled substances while the County PDMP focuses its efforts 
at the patient level by identifying high-risk patients.136 
IV.  DISCUSSION 
This Note provides a general overview of the history of PDMPs and the 
procedures that states undergo to implement them and examines the reasons 
why Missouri was the only state in the country that failed to enact a program 
for so long.  Next, this Part discusses how the prescription drug epidemic in the 
United States is a public health concern that warrants intervention by programs 
such as PDMPs.  This Part then examines the overarching benefits of PDMPs 
and how they outweigh potential ethical concerns.  Finally, this Part concludes 
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by discussing some of the privacy concerns that critics continue to boast in 
opposition to PDMPs. 
A.  The Prescription Drug Abuse Epidemic Is a Public Health Concern 
Like Nothing the United States Has Ever Seen 
This Note began by exploring some of the statistics related to the pre-
scription drug misuse epidemic sweeping the United States.  As mentioned ear-
lier, opioids account for the majority of prescription drug-related deaths and 
resulted in 42,249 deaths in 2016, with the total number of opioid-induced 
overdoses more than quadrupling since the late 1990s.137  Though these num-
bers are alarming, what is more alarming is that although the United States only 
consists of about five percent of the entire world’s population, more than eighty 
percent of the world’s opioid supply is consumed here.138  It is easy to see why 
drug overdoses, the majority of which are inflicted by prescription drugs, have 
become the number one cause of death across the country.139 
When analyzing the United States’ past encounters with national epidem-
ics, diseases such as smallpox, yellow fever, cholera, scarlet fever, and influ-
enza were considered epidemics.140  Though prescription drug abuse may not 
seem “epidemic” in most minds, it is an epidemic of greater proportion than 
the vast majority of prior scenarios.  In most cases, the outbreaks of past dis-
eases were rare, but the single connecting factor between all prior epidemics in 
the United States was that they were, for the most part, preventable.141 
Take, for example, the HIV/AIDS epidemic of the 1980s to 1990s and the 
mandatory blood testing that accompanied it.  The CDC estimated in August 
of 2016 that nearly 1.2 million people within the United States have contracted 
HIV, but as many as one in eight remain unaware of their infection.142  Though 
the HIV epidemic hit its peak in the late 1980s and early 1990s and numbers 
have steadily declined over the years, nearly 50,000 people in the United States 
are newly infected every year.143  In 2008, an article by the Washington Post 
went so far as to name HIV “the world’s No. 1 health threat,” and compulsory 
testing was warranted.144 
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This type of compulsory testing in situations where public health is at 
issue is not a foreign practice to the United States.  For example, when there 
was an outbreak of avian influenza (“Bird Flu”) in the United States in the late 
1900s and early 2000s, high-risk areas underwent mandatory testing proce-
dures, which subsequently greatly reduced the possibility of an outbreak.145  
Returning to the example of HIV testing, many of the newly emerging cases of 
HIV come to fruition due to pregnant HIV-infected mothers giving birth to 
children.146  Worldwide, this method of transmittal resulted in nearly 2.8 mil-
lion infected children in 2004.147  In the United States, blood testing is available 
to pregnant mothers to determine whether they are infected, as early treatment 
has been shown to reduce mother-to-child transmission by almost seventy per-
cent.148  Over the years, many states have pushed for mandatory testing of preg-
nant mothers, and other states have introduced legislation making testing of 
pregnant mothers compulsory.149 
The prescription drug abuse epidemic is no less imminent, critical, or fatal 
than Bird Flu or HIV/AIDS.  In situations such as this, where an epidemic ex-
ists and the means by which it may be subdued are available, difficult decisions 
must be made.  Each state and its legislature must make a judgment call regard-
ing the relative risk associated with the information being disclosed versus the 
public health benefit that can be reached.  Like many of the aforementioned 
diseases, the prescription drug abuse epidemic is preventable, but victims can-
not protect themselves by simply washing their hands, utilizing food safety 
techniques, or making sure to stay home if they are feeling ill.  Many who have 
fallen down the prescription drug abuse landslide need a helping hand.  In many 
cases, they need to be protected from themselves, and the most effective way 
to accomplish this is to enact and follow a state PDMP.  From a public policy 
and ethical perspective, PDMPs are not a burdensome violation of privacy but 
a logical and feasible means to an end of an epidemic. 
B.  Saving Lives, One State at a Time: The Benefits of PDMPs 
The benefits of PDMPs are both compelling and numerous.  Relating back 
to one of the primary goals of PDMPs – facilitating prescribers in dispensing a 
legitimate and medically necessary amount of controlled substances – PDMPs 
allow both prescribers and pharmacies access to information that promotes 
communication between prescribers, pharmacists, and patients regarding a pa-
tient’s prescription history.150  Access to this valuable information makes it 
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easier for physicians to avoid potentially double-dosing patients, to refrain 
from supplying controlled substances to doctor shoppers, and to alert patients 
of their potential substance abuse problem and subsequently direct them to 
clinical treatment when necessary.151  When enough physicians and pharmacies 
take part in a PDMP program and share access to patient histories, it makes it 
difficult for abusers and doctor shoppers to effectively “shop” the system for 
more controlled substances when the prescribers are interconnected.152 
Over the last decade, there have been increasing efforts in Florida to curb 
prescription drug abuse and diversion.153  During the 2000s, Florida was one 
of the leading states for “rogue pain management clinics” (more commonly 
referred to as “pill mills”) where controlled substances including opioids were 
improperly prescribed.154  The state addressed this problem in 2010 when it 
enacted legislation requiring mandatory registration of Florida’s pill mills with 
the state.  In 2011, Florida’s PDMP became operational and began collecting 
dispensing information across the state.155  The Journal of the American Med-
ical Association published a study in which the results were analyzed and com-
pared to the neighboring state of Georgia, which at that time lacked the same 
level of control procedures.156  The study “consisted of 2.6 million patients, 
431,890 prescribers and 2829 pharmacies” associated with “approximately 480 
million prescriptions” in Florida and Georgia.157  After only one year of the 
PDMP’s successful implementation, the study saw a decrease of 1.35% in opi-
oid prescriptions, 2.52% in opioid volume, and 5.64% “in mean [morphine mil-
ligram equivalent] . . . per transaction” when comparing between actual and 
predicted outcomes “had the policies not been implemented.”158  One year of 
compliance resulted in a moderate decrease in opioid misuse across the state.159  
Unfortunately, once Florida tightened its controlled substance monitoring, 
Missouri – specifically, St. Louis – with its lack of monitoring, soon became 
the epicenter of these rouge pain management clinics.160 
In an effort to strike a balance between decreasing prescription drug abuse 
and preserving patient access to necessary controlled substances, the American 
Academy of Hospice and Palliative Medicine (“AAHPM”) recently published 
a guide produced by its State Issues Working Group to serve as guidelines for 
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effective PDMP usage.161  The guide states that the most effective state PDMPs 
are structured with prescribers and dispensers in mind and that the programs 
“ensur[e] interoperability and HIPAA-complaint data sharing across . . . state 
lines,” “includ[e] prescribers and dispensers in the development and ongoing 
review of a PDMP,” and “foster[] efficient point-of-care access to prescription 
data and reporting mechanisms.”162 
Further, AAHPM’s guide urges that PDMPs “should maintain a health 
care focus,” reiterating the principle mentioned above that PDMPs should not 
serve as a law enforcement tool because when they do, both health care pro-
viders as well as patients “may fear excessive or punitive scrutiny.”163  The 
AAHPM stresses that PDMPs “should exist chiefly as a tool for improving 
patient care and safety,” which can be achieved by “requiring external over-
sight and approval of law enforcement requests to access PDMP data” and by 
“providing options for law enforcement access that protect the confidentiality 
of patients’ sensitive information.”164 
Finally, the AAHPM’s guide to effective PDMP procedures emphasizes 
that PDMP objectives should be “reinforced through other policies.”165  These 
policies include “dismantling ‘pill mills’ by requiring that pain clinics be phy-
sician-owned and that an expert-level prescriber [be] actively involved in the 
management of daily clinical activities.”166  This practice was evidently suc-
cessful in Florida,167 and there is no justification as to why it would not have 
the same curbing effect in Missouri.  With the increasing number of pill mills 
in St. Louis, the adoption of policies akin to Florida’s procedure coupled with 
Governor Greiten’s recent executive order would likely be effective in com-
batting the opioid crisis in Missouri. 
C.  Potential Privacy Problems 
Some draw pause with respect to programs like PDMPs because they 
have the potential, when not properly constructed or administered, to present 
various legal or ethical obstacles.168  For example, cases like the Florida169 and 
Utah170 privacy breaches leave some on edge with regards to the overall safety 
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of PDMPs; however, as examined above,171 Missouri’s current PDMP legisla-
tion is constructed in a way that avoids the potential privacy intrusions experi-
enced in the Florida and Utah cases.172 
The reality is that few individuals have access to the majority of these 
programs.  For example, forty-nine states allow access to PDMP information 
by physicians, dispensers, licensing/regulatory boards, and law enforcement 
officials as “authorized users” of the programs.173  Also, eighteen states only 
allow access by law enforcement officials after officials have received a court-
issued subpoena or search warrant, thus requiring probable cause to gain access 
to the records.174  Therefore, the select individuals who have access to patient 
information are most commonly medical professionals who understand the im-
portance of privacy laws such as HIPAA. 
The overarching goal of PDMPs is not to operate as a law enforcement 
tool but to serve as a clinical instrument to help identify abuse and misuse of 
controlled substances.175  The United States has an extensive history of infring-
ing upon individual rights in cases of epidemics,176 and privacy rights are no 
exception.  With people dying each day from prescription drug overdoses,177 
this public health crisis must be apprehended.  Personal privacy is important, 
but public health is necessary to preserve life within a community. 
V.  CONCLUSION 
The sole reason Missouri was unable to pass PDMP legislation over the 
past several years centered around unsupported and flawed reasoning.  Critics 
opposing a PDMP in Missouri argued over the privacy concerns associated 
with the passage of this legislation.  They argued that PDMPs are intrusive and 
threaten personal liberty.  They argued that because the population of Missouri 
citizens actively abusing drugs is low, there was not a compelling interest to 
implement a PDMP.  However, Missouri’s recently-enacted PDMP legislation 
provides that a court-issued subpoena or a search warrant is required for law 
enforcement to access Missouri’s database, thus providing protective measures 
for these privacy concerns.  With a prescription drug induced death rate higher 
than the national average, Missouri was in dire need of a PDMP. 
 
 171. See supra notes 103–05. 
 172. Missouri Final State to Implement PDMP, supra note 136.  It is currently un-
clear whether Missouri’s Statewide PDMP will mirror the same construction as the St. 
Louis County PDMP with respect to potential privacy intrusions, but Governor Greit-
ens has not given any indication as to why it would not.  Id. 
 173. NAT’L ALL. FOR MODEL STATE DRUG LAWS, ANNUAL REVIEW OF 
PRESCRIPTION MONITORING PROGRAMS 4 (Dec. 2014), http://www.namsdl.org/li-
brary/3449DDCF-BB94-288B-049EB9A92BAD73DF/. 
 174. Id. at 25. 
 175. See id. at 2. 
 176. See supra notes 145–49. 
 177. Opioid Overdose, supra note 5. 
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In situations of national epidemics such as this, the state and the legisla-
tive branch must come together to make a tough judgment call.  They must 
exercise judgment regarding the relative risk associated with the data being 
disclosed in PDMPs and the public health benefit that can and likely will be 
reached.  Policymakers must create and utilize the most reasonable and prag-
matic strategies possible to combat prescription drug abuse.  PDMP data not 
only improves public safety by working to reduce drug diversion, but it is also 
a powerful public health tool that forty-nine other states have learned works.  
Thankfully, Missouri finally joined the rest of the United States in the fight 
against prescription drug abuse.  Had Governor Greitens not instituted an ex-
ecutive order requiring the implementation of a PDMP for Missouri, citizens 
would likely have continued to flood into the Show-Me state to “doctor shop 
until they dropped.” 
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